MarketWatch | Mylan announces launch of Mycophenolic Acid Delayed-release Tablets News-Medical.net Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic® Delayed-release ... Mylan Launches Generic Myfortic® Delayed-Release Tablets Mylan Launches Generic Myfortic |
